A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

Psychopharmacology

Volumn 124, Issue 1-2, 1996, Pages 168-175

  Van Kammen, Daniel P ^a   McEvoy, Joseph P ^b   Targum, Steven David ^c   Kardatzke, David ^d   Sebree, TerrI B ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b John Umstead Hospital   (United States)

^c CROZER CHESTER MEDICAL CENTER   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

Extrapyramidal symptoms; Neuroleptics; Placebo; Schizophrenia; Sertindole

Indexed keywords

BENZATROPINE; BENZATROPINE MESILATE; CHLORAL HYDRATE; LORAZEPAM; NEUROLEPTIC AGENT; PLACEBO; SERTINDOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHIATRY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINITIS; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SYMPTOMATOLOGY;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMIDAZOLES; INDOLES; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 0029916389     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02245618     Document Type: Article

References (20)

1. Arnt J (1992) Sertindole and several antipsychotic drugs differentially inhibit the discriminative stimulus effects of amphetamine, LSD, and St 587 in rats. Behav Pharmacol 3:11-18
2. Baldessarini RJ, Huston-Lyons D, Campbell A, Marsh E, Cohen BM (1992) Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry 160 [suppl 17]12-16
3. Bunney BS (1984) Antipsychotic drug effects on the electrical activity of dopaminergic neurons. Trends Neurosci 7:212-215
4. Casey DE (1996) Behavioral effects of sertindole, risperidone, clozapine, and haloperidol in Cebus monkeys. Psychopharmacology 124:134-140
5. COSTART (1989) Coding symbols for thesaurus of adverse reaction terms (3rd edn). Department of Health and Human Services, Food and Drug Administration, Center for Drugs and Biologics, Division of Drug and Biological Product Experience. Rockville, Md
6. Daniel D, Targum S, Zimbroff D, Mack R, Zborowski J, Morris D, Sebree T, Wallin B (1995) Efficacy, safety, and dose response of three doses of sertindole and three doses of haldol in schizophrenic patients. Abstract, Meeting of the American College of Neuropsychopharmacology, Dec 10-15
7. Domeney AM, Arnt J, Costall B, Naylor RJ, Sánchez C, Smith AG (1994) Effect of sertindole on raised mesolimbic dopaminergic activity in the rat. Drug Dev Res 31:175-185
8. Goldstein JM (1995) Central and peripheral nervous systems: pre-clinical pharmacology of new atypical antipsychotics in late stage development. Exp Opin Invest Drugs 4:291-298
9. Grebb JA, Sebree T, Schmitz P, Kashkin K (1993) A placebo-controlled trial of sertindole in schizophrenia. Presented at the twenty-third annual meeting of the American College of Neuropsychopharmacology, Honolulu, Hawaii
10. Hyttel J (1991) Sertindole - a new concept in neuroleptic research. In: Modern trends in the treatment of schizophrenia: proceedings of a symposium. Excerpta Medica, Princeton, pp 3-12
11. α1 receptors (ex vivo radioreceptor binding studies). J Neural Transm 89:61-69
12. 3 receptors. Mol Pharmacol 43:749-754
13. Meltzer HY, Nash FJ (1991) VII. Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43:587-604
14. Meltzer HY, Gudelsky GA (1992) Dopaminergic and serotonergic effects of clozapine: implications for a unique clinical profile. Arzneimittelforschung 42:268
15. McEvoy J, Borison R, Small J, Van Kammen D, Melzer H, Hamner M, Morris D, Shu V, Sebree T, Grebb J, Kashkin K (1993) The efficacy and tolerability of sertindole in schizophrenic patients: a pilot, double-blind, placebo-controlled, dose-ranging study. Schizophr Res 9 [2, 3]:244
16. Sánchez C, Arnt J, Dragsted N, Hyttel J, Lembøl HL, Meier E, Perregaard J, Skarsfeldt T (1991) Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Dev Res 22:239-250
17. SAS Institute, Inc (1991) SAS user's guide: statistics, version 6 edition. SAS Institute, Cary, NC
18. Skarsfeldt T (1992) Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment. Synapse 10:25-33
19. Trimble MR, Zarifian E (1985) Psychopharmacology of the limbic system. Br Assoc Psych, Monograph #5, Oxford University Press
20. Van Elteren PH (1960) On the combination of independent two sample tests of Wilcoxon. Bull Inst Int Statist 37:351-361